These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32851029)

  • 1. Treatment With Hydrolyzed Diet Supplemented With Prebiotics and Glycosaminoglycans Alters Lipid Metabolism in Canine Inflammatory Bowel Disease.
    Ambrosini YM; Neuber S; Borcherding D; Seo YJ; Segarra S; Glanemann B; Garden OA; Müller U; Adam MG; Dang V; Borts D; Atherly T; Willette AA; Jergens A; Mochel JP; Allenspach K
    Front Vet Sci; 2020; 7():451. PubMed ID: 32851029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of prebiotics and glycosaminoglycans versus placebo In dogs with food responsive enteropathy receiving a hydrolyzed diet: A pilot study.
    Glanemann B; Seo YJ; Priestnall SL; Garden OA; Kilburn L; Rossoni-Serao M; Segarra S; Mochel JP; Allenspach K
    PLoS One; 2021; 16(10):e0250681. PubMed ID: 34673776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.
    Segarra S; Martínez-Subiela S; Cerdà-Cuéllar M; Martínez-Puig D; Muñoz-Prieto A; Rodríguez-Franco F; Rodríguez-Bertos A; Allenspach K; Velasco A; Cerón J
    BMC Vet Res; 2016 Mar; 12():49. PubMed ID: 26965834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease.
    Minamoto Y; Otoni CC; Steelman SM; Büyükleblebici O; Steiner JM; Jergens AE; Suchodolski JS
    Gut Microbes; 2015; 6(1):33-47. PubMed ID: 25531678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment.
    Kalenyak K; Heilmann RM; van de Lest CHA; Brouwers JF; Burgener IA
    PLoS One; 2019; 14(4):e0215435. PubMed ID: 30990833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
    Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
    World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease.
    Luckschander N; Allenspach K; Hall J; Seibold F; Gröne A; Doherr MG; Gaschen F
    J Vet Intern Med; 2006; 20(2):221-7. PubMed ID: 16594575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Preliminary Study of Modulen IBD Liquid Diet in Hospitalized Dogs with Protein-Losing Enteropathy.
    Kathrani A; Parkes G
    Animals (Basel); 2022 Jun; 12(12):. PubMed ID: 35739930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the intestinal mucosal microbiota in dogs diagnosed with idiopathic inflammatory bowel disease and dogs with food-responsive diarrhea before and after treatment.
    Kalenyak K; Isaiah A; Heilmann RM; Suchodolski JS; Burgener IA
    FEMS Microbiol Ecol; 2018 Feb; 94(2):. PubMed ID: 29228248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M; Hörauf A; Bilzer T
    Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
    Guo M; Zhang J
    Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of a Synbiotic Containing
    Pilla R; Guard BC; Steiner JM; Gaschen FP; Olson E; Werling D; Allenspach K; Salavati Schmitz S; Suchodolski JS
    Front Vet Sci; 2019; 6():277. PubMed ID: 31552278
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum metabolomics analysis reveals that weight loss in obese dogs results in a similar metabolic profile to dogs in ideal body condition.
    Vendramini THA; Macedo HT; Zafalon RVA; Macegoza MV; Pedrinelli V; Risolia LW; Ocampos FMM; Jeremias JT; Pontieri CFF; Ferriolli E; Colnago LA; Brunetto MA
    Metabolomics; 2021 Feb; 17(3):27. PubMed ID: 33594460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary leukotriene E4 concentrations as a potential marker of inflammation in dogs with inflammatory bowel disease.
    Im Hof M; Schnyder M; Hartnack S; Stanke-Labesque F; Luckschander N; Burgener IA
    J Vet Intern Med; 2012; 26(2):269-74. PubMed ID: 22268894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease.
    Atherly T; Rossi G; White R; Seo YJ; Wang C; Ackermann M; Breuer M; Allenspach K; Mochel JP; Jergens AE
    PLoS One; 2019; 14(12):e0226780. PubMed ID: 31887117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted metabolomics analysis for serum Helicobacter pylori-positive based on liquid chromatography-tandem mass spectrometry.
    Wang J; Shan J; Zhang Y; Shi Y; Lu D; Wu Y; Guo XP; Liu H; Wang J; Hu N
    Biomed Chromatogr; 2023 Jun; 37(6):e5622. PubMed ID: 36898359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
    Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
    Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis.
    Guan S; Jia B; Chao K; Zhu X; Tang J; Li M; Wu L; Xing L; Liu K; Zhang L; Wang X; Gao X; Huang M
    J Proteome Res; 2020 Feb; 19(2):600-609. PubMed ID: 31821004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary trial using a commercial hypoallergenic diet containing hydrolyzed protein for dogs with inflammatory bowel disease.
    Marks SL; Laflamme DP; McAloose D
    Vet Ther; 2002; 3(2):109-18. PubMed ID: 19750741
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.